SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12648862
Source:
http://linkedlifedata.com/resource/pubmed/id/12648862
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0060657
,
umls-concept:C0205276
,
umls-concept:C0332281
,
umls-concept:C0392747
,
umls-concept:C0443172
,
umls-concept:C0474701
,
umls-concept:C1280500
pubmed:issue
2
pubmed:dateCreated
2003-3-21
pubmed:abstractText
The aim of the study was to determine whether a beta(2)-adrenoceptor agonist, formoterol, inhibits premature delivery in connection with change in estradiol and progesterone concentrations in the amniotic fluid in ovariectomized rats.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0375672
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Dinoprost
,
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol
,
http://linkedlifedata.com/resource/pubmed/chemical/Ethanolamines
,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9
,
http://linkedlifedata.com/resource/pubmed/chemical/Progesterone
,
http://linkedlifedata.com/resource/pubmed/chemical/Tocolytic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/formoterol
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0301-2115
pubmed:author
pubmed-author:OkumuraYutakaY
,
pubmed-author:SaitoHideoH
,
pubmed-author:SasakiHiroyukiH
,
pubmed-author:ShinkaiNorihiroN
,
pubmed-author:TakasunaKiyoshiK
,
pubmed-author:TakayamaSatoshiS
pubmed:copyrightInfo
Copyright 2002 Elsevier Science Ireland Ltd.
pubmed:issnType
Print
pubmed:day
25
pubmed:volume
107
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
163-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12648862-Adrenergic beta-Agonists
,
pubmed-meshheading:12648862-Amniotic Fluid
,
pubmed-meshheading:12648862-Animals
,
pubmed-meshheading:12648862-Dinoprost
,
pubmed-meshheading:12648862-Estradiol
,
pubmed-meshheading:12648862-Ethanolamines
,
pubmed-meshheading:12648862-Female
,
pubmed-meshheading:12648862-Matrix Metalloproteinase 9
,
pubmed-meshheading:12648862-Obstetric Labor, Premature
,
pubmed-meshheading:12648862-Ovariectomy
,
pubmed-meshheading:12648862-Pregnancy
,
pubmed-meshheading:12648862-Progesterone
,
pubmed-meshheading:12648862-Rats
,
pubmed-meshheading:12648862-Tocolytic Agents
pubmed:year
2003
pubmed:articleTitle
Tocolytic effects of formoterol are associated with local change in the progesterone/estradiol ratio.
pubmed:affiliation
Daiichi Pharmaceutical Co Ltd, 8-1 Minamisakae-cho, Kasukabe, Saitama 344-0067, Japan. shinkai@sdsk.co.jp
pubmed:publicationType
Journal Article